Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 17;18(4):848.
doi: 10.3390/ijms18040848.

Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary?

Affiliations
Review

Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary?

Fabrizio Buffolo et al. Int J Mol Sci. .

Abstract

Aldosterone producing adenoma and bilateral adrenal hyperplasia are the two most common subtypes of primary aldosteronism (PA) that require targeted and distinct therapeutic approaches: unilateral adrenalectomy or lifelong medical therapy with mineralocorticoid receptor antagonists. According to the 2016 Endocrine Society Guideline, adrenal venous sampling (AVS) is the gold standard test to distinguish between unilateral and bilateral aldosterone overproduction and therefore, to safely refer patients with PA to surgery. Despite significant advances in the optimization of the AVS procedure and the interpretation of hormonal data, a standardized protocol across centers is still lacking. Alternative methods are sought to either localize an aldosterone producing adenoma or to predict the presence of unilateral disease and thereby substantially reduce the number of patients with PA who proceed to AVS. In this review, we summarize the recent advances in subtyping PA for the diagnosis of unilateral and bilateral disease. We focus on the developments in the AVS procedure, the interpretation criteria, and comparisons of the performance of AVS with the alternative methods that are currently available.

Keywords: adrenal vein sampling; aldosterone; aldosterone producing adenoma; bilateral adrenal hyperplasia; cosyntropin stimulation; primary aldosteronism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Käyser S.C., Dekkers T., Groenewoud H.J., van der Wilt G.J., Carel Bakx J., van der Wel M.C., Hermus A.R., Lenders J.W., Deinum J. Study heterogeneity and estimation of prevalence of primary aldosteronism: A systematic review and meta-regression analysis. J. Clin. Endocrinol. Metab. 2016;101:2826–2835. doi: 10.1210/jc.2016-1472. - DOI - PubMed
    1. Monticone S., Burrello J., Tizzani D., Bertello C., Viola A., Buffolo F., Gabetti L., Mengozzi G., Williams T.A., Rabbia F., Veglio F., Mulatero P. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J. Am. Coll. Cardiol. 2017;69:1811–1820. doi: 10.1016/j.jacc.2017.01.052. - DOI - PubMed
    1. Mulatero P., Tizzani D., Viola A., Bertello C., Monticone S., Mengozzi G., Schiavone D., Williams T.A., Einaudi S., La Grotta A., et al. Prevalence and characteristics of familial hyperaldosteronism: The PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms) Hypertension. 2011;58:797–803. doi: 10.1161/HYPERTENSIONAHA.111.175083. - DOI - PubMed
    1. Milliez P., Girerd X., Plouin P.-F., Blacher J., Safar M.E., Mourad J.-J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol. 2005;45:1243–1248. doi: 10.1016/j.jacc.2005.01.015. - DOI - PubMed
    1. Mulatero P., Monticone S., Bertello C., Viola A., Tizzani D., Iannaccone A., Crudo V., Burrello J., Milan A., Rabbia F., et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J. Clin. Endocrinol. Metab. 2013;98:4826–4833. doi: 10.1210/jc.2013-2805. - DOI - PubMed